PDS Biotechnology Corporation

PDS Biotechnology Corporation is an established biotech entity specialising in the development of immunotherapies to combat various forms of cancer and infectious diseases. With operations spanned globally, its focus is pioneering novel approaches to bolster the body's immune defence. In the broader biotechnology sector, PDS Biotechnology stands out for its unique Versamune platform. Ots immunotherapies are designed to stimulate the body's immune system to selectively target and kill cancer cells while preventing disease recurrence. Diversify your portfolio by following PDSB shares on eToro.